Correlation Between Mink Therapeutics and Abeona Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Abeona Therapeutics, you can compare the effects of market volatilities on Mink Therapeutics and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Abeona Therapeutics.

Diversification Opportunities for Mink Therapeutics and Abeona Therapeutics

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Mink and Abeona is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Abeona Therapeutics go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Abeona Therapeutics

Given the investment horizon of 90 days Mink Therapeutics is expected to generate 4.31 times more return on investment than Abeona Therapeutics. However, Mink Therapeutics is 4.31 times more volatile than Abeona Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Abeona Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  630.00  in Mink Therapeutics on December 28, 2024 and sell it today you would earn a total of  220.00  from holding Mink Therapeutics or generate 34.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Mink Therapeutics  vs.  Abeona Therapeutics

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mink Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady forward-looking signals, Mink Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Abeona Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Abeona Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Mink Therapeutics and Abeona Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Abeona Therapeutics

The main advantage of trading using opposite Mink Therapeutics and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.
The idea behind Mink Therapeutics and Abeona Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios